{"DataElement":{"publicId":"3772622","version":"1","preferredName":"Tumor Marker CA-19-9 Test  Range","preferredDefinition":"information related to a test for tumor marker CA-19-9._The reported range in the value of a test for tumor marker CA19-9 used for  protocol stratification.","longName":"TMMKR_CA-19-9_TST_Rang","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"2192294","version":"1","preferredName":"Tumor Marker CA-19-9 Test","preferredDefinition":"information related to a test for tumor marker CA-19-9.","longName":"TMMKR_CA-19-9_TST","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2443094","version":"1","preferredName":"Tumor Marker","preferredDefinition":"A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","longName":"C17220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A400EF7-3DF6-3538-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-16","endDate":null,"createdBy":"PWEST","dateCreated":"2006-01-16","modifiedBy":"ONEDATA","dateModified":"2006-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207090","version":"3","preferredName":"CA19-9 Antigen Test","preferredDefinition":"CA19-9 is a carbohydrate often found in elevated levels in patients with carcinoma of the pancreas or gastrointestinal tract.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"CA19-9","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CA19-9 Antigen","conceptCode":"C327","definition":"CA 19-9 is a fucosylated glycosphingolipid carbohydrate antigen that is soluble and is adsorbed to erythrocytes and to many adenocarcinomas of the digestive tract, especially pancreatic tumors. By structure CA 19-9 is related to the Lewis blood group antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C234BF7-4C07-0FD0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-29","endDate":null,"createdBy":"DWARZEL","dateCreated":"2006-08-29","modifiedBy":"ONEDATA","dateModified":"2006-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E915505A-2B71-0390-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to use fixed NCI Concept for CA19-19 Antigen with correct NCI Thesaurus mapping.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3772613","version":"1","preferredName":"CA19-9 Test Range","preferredDefinition":"The reported range in the value of a test for tumor marker CA19-9 used for  protocol stratification.","longName":"Rang","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"2","valueDescription":"Greater than 90 to 180","ValueMeaning":{"publicId":"3772614","version":"1","preferredName":"Greater than 90 to 180","longName":"3772614","preferredDefinition":"Greater than 90 to 180","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDDF73CB-FEB7-4EE4-E040-BB89AD432F95","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDDF73CB-FED0-4EE4-E040-BB89AD432F95","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"ONEDATA","dateModified":"2013-05-29","deletedIndicator":"No"},{"value":"1","valueDescription":"Less than or equal to 90","ValueMeaning":{"publicId":"3772615","version":"1","preferredName":"Less than or equal to 90","longName":"3772615","preferredDefinition":"Less than or equal to 90","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDDF73CB-FEDA-4EE4-E040-BB89AD432F95","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDDF73CB-FEF3-4EE4-E040-BB89AD432F95","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"ONEDATA","dateModified":"2013-05-29","deletedIndicator":"No"},{"value":"Less than or equal to 90","valueDescription":"Less than or equal to 90","ValueMeaning":{"publicId":"3772615","version":"1","preferredName":"Less than or equal to 90","longName":"3772615","preferredDefinition":"Less than or equal to 90","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDDF73CB-FEDA-4EE4-E040-BB89AD432F95","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF9FC81C-34A7-3039-E040-BB89AD436625","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2014-01-10","modifiedBy":"ONEDATA","dateModified":"2014-01-10","deletedIndicator":"No"},{"value":"Greater than 90 to 180","valueDescription":"Greater than 90 to 180","ValueMeaning":{"publicId":"3772614","version":"1","preferredName":"Greater than 90 to 180","longName":"3772614","preferredDefinition":"Greater than 90 to 180","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDDF73CB-FEB7-4EE4-E040-BB89AD432F95","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF9FC81C-34BB-3039-E040-BB89AD436625","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2014-01-10","modifiedBy":"ONEDATA","dateModified":"2014-01-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433750","version":"1","preferredName":"Range","preferredDefinition":"Range; the difference between the lowest and highest numerical values.","longName":"C38013","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Range","conceptCode":"C38013","definition":"The difference between the lowest and highest numerical values; the limits or scale of variation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"06674CCB-CBE3-04A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-26","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-26","modifiedBy":"ONEDATA","dateModified":"2005-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDDF73CB-FEA4-4EE4-E040-BB89AD432F95","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"GRANTD","dateModified":"2014-04-02","changeDescription":"Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"}]}],"AlternateNames":[{"name":"TMMKR_CA-19-9_TST_Rang","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CA-19-9","type":"Preferred Question Text","description":"CA-19-9","url":null,"context":"NRG"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE00C8E-F3B2-5C6C-E040-BB89AD435A7B","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-29","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":"Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}